Rheumatology Review Course 2023
Activity Overview
The Rheumatology Review Course 2023 features key updates covering a wide range of rheumatology diseases. This activity contains eight individual video lectures approximately 45 minutes in length, including a Q&A session, and is ideal for anyone needing an introduction to the latest research in rheumatology or simply seeking an activity available at your convenience.
The Review Course is a popular session that takes place annually during ACR Convergence, the ACR’s annual meeting. Topics from the 2023 activity include:
- Inflammatory eye disease diagnosis and treatment
- Transition in juvenile idiopathic arthritis (JIA) care
- Thrombotic microangiopathy
- Relapsing polychondritis
- Radiographic and non-radiographic ankylosing spondylitis
- Systemic sclerosis screening for organ involvement
- Reproductive counseling
- Viral infections and rheumatic diseases
Target Audience
Rheumatologists, primary care providers physician assistants, fellows in training, advanced practice nurses, and rheumatology interprofessionals who care for patients with rheumatic diseases; professionals interested or engaged in rheumatology research.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Summarize up-to-date assessment and management strategies in inflammatory eye disease, polychondritis, and other rheumatic diseases
- Identify current imaging modalities used to diagnose scleroderma, axial spondyloarthritis and thrombotic microangiopathy
- Develop skills to facilitate open and accurate discussions about pregnancy prevention and planning
- Define Juvenile Idiopathic Arthritis (JIA) including its etiology, symptoms, and common treatments
- Demonstrate understanding of the unique challenges faced by young adults living with JIA
CE & MOC Information
CME
ACCME Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.See the ACR's CME Mission Statement. For more information, download the AMA PRA Booklet.
AMA Designation Statement
The American College of Rheumatology designates this Enduring Material for a maximum of 6.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME credit must be claimed by July 25, 2027, at 11:59 PM ET.
MOC
MOC Recognition Statement: American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.
After submitting a
reflective statement with key takeaways from the activity, MOC points will be
applied for ABIM diplomates to the ABIM diplomate number and date of birth
provided when you registered. Points are sent nightly to ACCME and then
transferred to the ABIM Physician Portal. Please allow at least 48 hours for
points to display in the portal.
MOC Recognition Statement: American Board of Pediatrics (ABP)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 6.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABP diplomates to the ABP diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABP Physician Portals. Please allow at least 48 hours for points to display in the portal.
MOC points must be claimed by July 25, 2027, at 11:59 PM ET.
Financial Relationship Disclosures
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.
Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
- Advisor or review panel member
- Consultant
- Employee
- Officer or Board Member
- Grant/research support
- Speaker/honoraria includes speaker’s bureau, symposia, and expert witness
- Independent contractor
- Executive role and/or ownership interest
- Royalties and/or patent beneficiary
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Private investigator
- Expert witness
- Equity interest
- Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated. Rheumatology Review Course 2023 Financial Relationship Disclosures.
Acknowledgement of Commercial Support
No commercial support was provided for this activity.